Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review.

Li, Hua; Fu, Zhi-Yan; Arslan, Mustafa Erdem; Cho, Daniel; Lee, Hwajeong

Li, Hua; Fu, Zhi-Yan; Arslan, Mustafa Erdem; Cho, Daniel; Lee, Hwajeong.

Affiliation

Li H; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, United States.
Fu ZY; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, United States.
Arslan ME; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, United States.
Cho D; Schenectady Pathology Associates, Ellis Hospital, Schenectady, NY 12308, United States.
Lee H; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, United States. leeh5@amc.edu.

World J Exp Med ; 11(6): 79-92, 2021 Dec 30.

Article de En | MEDLINE | ID: mdl-36246150

Mots clés

Graft-versus-host disease; Immune checkpoint inhibitor; Immune checkpoint inhibitor-induced colitis; Inflammatory bowel disease; Infliximab; Vedolizumab

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies Langue: En Journal: World J Exp Med Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google